Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.

Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.

BACKGROUND: Osteoprotegerin (OPG) is a tumour and/or bone derived factor that may protect tumour cells from apoptosis. In this study, we have measured serum OPG levels in untreated prostate cancer patients with advanced prostate cancer compared to patients with organ confined disease and in treated...

Podrobná bibliografie
Hlavní autoři:	Eaton, C, Wells, J, Holen, I, Croucher, P, Hamdy, F
Médium:	Journal article
Jazyk:	English
Vydáno:	2004

Podobné jednotky

Serum osteoprotegerin (OPG) levels and disease progression in prostate cancer patients
Autor: Eaton, C, a další
Vydáno: (2004)

Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.
Autor: Holen, I, a další
Vydáno: (2002)

Osteoprotegerin is an anti-apoptotic factor produced by prostate cancer cells that is potentially involved in tumour survival and progression.
Autor: Holen, I, a další
Vydáno: (2002)

Role of osteoprotegerin (OPG) in cancer.
Autor: Holen, I, a další
Vydáno: (2006)

The role of osteoprotegerin in breast and prostate cancer
Autor: Holen, I, a další
Vydáno: (2002)

OPG is a survival factor for breast- and prostate cancer cells in vitro
Autor: Holen, I, a další
Vydáno: (2002)

Polymorphisms within the osteoprotegerin (OPG) gene are associated with both serum OPG levels and bone mineral density.
Autor: Miles, L, a další
Vydáno: (2004)

Serum osteoprotegerin (OPG) in children with primary nephrotic syndrome
Autor: Gamal B Mohamed, a další
Vydáno: (2011-01-01)

Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact
Autor: Holen Ingunn, a další
Vydáno: (2009-07-01)

Role of Osteoprotegerin (OPG) in Bone Marrow Adipogenesis
Autor: Lili Zhang, a další
Vydáno: (2016-11-01)

Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms
Autor: Riham Eid, a další
Vydáno: (2023-06-01)

Significant Inverse Correlation of Serum Levels of Osteoprotegerin (OPG) and Transferrin Saturation in Thalassemia Dependent Transfusion (TDT) Patients
Autor: Indra Wijaya, a další
Vydáno: (2024-01-01)

Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.
Autor: Croucher, P, a další
Vydáno: (2000)

Effect of Ibandronate Therapy on Serum Chemerin, Vaspin, Omentin-1 and Osteoprotegerin (OPG) in Postmenopausal Osteoporotic Females
Autor: Saba Tariq, a další
Vydáno: (2022-02-01)

Myeloma cells can down-regulate release of osteoprotegerin (OPG) from human bone cells - A contributing factor in myeloma bone loss?
Autor: Shipman, C, a další
Vydáno: (2002)

Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19
Autor: Siamak Kazemi-Sufi, a další
Vydáno: (2024-09-01)

Myeloma cells isolated from patients with multiple myeloma express osteoprotegerin ligand.
Autor: Shipman, C, a další
Vydáno: (2000)

Osteoprotegerin (OPG) is a soluble decoy receptor for TRAIL/Apo2L and can inhibit TRAIL/Apo2L-induced apoptosis of human myeloma cells in vitro.
Autor: Shipman, C, a další
Vydáno: (2002)

Endogenous osteoprotegerin (OPG) represses ERα and promotes stemness and chemoresistance in breast cancer cells
Autor: Noura N. Alraouji, a další
Vydáno: (2024-08-01)

Alendronate (ALN) combined with Osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats
Autor: Chan Kai-Ming, a další
Vydáno: (2011-07-01)

Osteoprotegerin (OPG): A potential biomarker for adverse cardiovascular events in stable coronary artery disease
Autor: Syed Muhammad Muneeb Akhtar, a další
Vydáno: (2024-07-01)

The antibody MAB8051 directed against osteoprotegerin detects carbonic anhydrase II: implications for association studies with human cancers.
Autor: Waterman, E, a další
Vydáno: (2007)

Effect of androgen deprivation therapy on serum levels of sclerostin, Dickkopf-1, and osteoprotegerin: a cross-sectional and longitudinal analysis
Autor: Alice Wang, a další
Vydáno: (2021-07-01)

Analysis of periodontal parameteres and salivary levels of Receptor Activator of NF- κβ Ligand (RANKL) and Osteoprotegerin (OPG) in obese periodontitis patients
Autor: Cheema, Raheem Ramzan
Vydáno: (2021)

Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts
Autor: Yao Jing, a další
Vydáno: (2011-03-01)

Changes of serum osteoprotegerin level in recurrent urolithiasis
Autor: A. V. Savilov, a další
Vydáno: (2023-10-01)

Can androgen receptor levels in the prostate predict non-organ-confined prostate cancer?
Autor: Hamdy, F
Vydáno: (2005)

Osteoprotegerin and the development of myeloma bone disease
Autor: Croucher, P, a další
Vydáno: (2004)

Dickkopf-1 levels and serum Osteoprotegerin in women with Osteoporosis
Autor: Mehrzad Hajialilo, a další
Vydáno: (2013-12-01)

Serum levels of OPG, RANKL and RANKL/OPG ratios in newly-diagnosed patients with multiple myeloma. Clinical correlations
Autor: Veselina Goranova-Marinova, a další
Vydáno: (2007-07-01)

Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers
Autor: Martin Widschwendter, a další
Vydáno: (2015-10-01)

Enhancing androgen ablation response in metastatic hormone-sensitive prostate cancer: the benefits of transurethral resection of the prostate
Autor: Yan Zhao, a další
Vydáno: (2023-07-01)

Rapid Androgen-Responsive Proteome Is Involved in Prostate Cancer Progression
Autor: Jong-Kwang Kim, a další
Vydáno: (2021-12-01)

The influence of vitamin D administration on the clinical presentation, body mass index, and osteoprotegerin (OPG) level in a sample of Egyptian children with familial Mediterranean fever
Autor: Hanaa Reyad Abdallah, a další
Vydáno: (2021-12-01)

Osteoprotegerin, sclerostin, and osteocalcin serum levels in thyroid disorder patients
Autor: F. F. Rija, a další
Vydáno: (2021-10-01)

Serum Osteoprotegerin Levels and the Vascular Reactivity Index in Patients with Hypertension
Autor: Yen-Liang Chen, a další
Vydáno: (2023-10-01)

Investigation of the effect of hydroalcoholic mumie extract on expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL)
Autor: Yosra Azizpour, a další
Vydáno: (2020-01-01)

Investigation of the effect of hydroalcoholic mumie extract on expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL)
Autor: Yosra Azizpour, a další
Vydáno: (2020-01-01)

Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
Autor: Croucher, P, a další
Vydáno: (2003)

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
Autor: Croucher, P, a další
Vydáno: (2001)